{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:05:55Z","timestamp":1780484755118,"version":"3.54.1"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"HI"},{"name":"LI"},{"name":"CNS"},{"name":"SIP"},{"name":"InterVivo Solutions Inc"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.neuropharm.2020.108064","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T19:54:53Z","timestamp":1585166093000},"page":"108064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Effects of 5-HT2C receptor modulation and the NA reuptake inhibitor atomoxetine in tests of compulsive and impulsive behaviour"],"prefix":"10.1016","volume":"170","author":[{"given":"Guy A.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"St John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cam","family":"MacMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo B.","family":"Silenieks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Thevarkunnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2020.108064_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biopsych.2010.03.004","article-title":"Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia","volume":"68","author":"Amitia","year":"2010","journal-title":"Biol. Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2020.108064_bib2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/acschemneuro.5b00094","article-title":"Serotonin (5-HT) 5-HT2A receptor (5-HT2AR):5-HT2CR imbalance in medial prefrontal cortex Associates with motor impulsivity","volume":"6","author":"Anastasio","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/npp.2013.199","article-title":"Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence","volume":"39","author":"Anastasio","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108064_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.biopsych.2013.09.031","article-title":"Atomoxetine decreases vulnerability to develop compulsivity in high impulsive rats","volume":"75","author":"Ansquer","year":"2014","journal-title":"Biol. Psychiatr."},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108064_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2020.108064_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-011-2576-x","article-title":"Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats","volume":"219","author":"Baarendse","year":"2012","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108064_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision","volume":"9","author":"Bandelow","year":"2012","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108064_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nprot.2008.41","article-title":"The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats","volume":"3","author":"Bari","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2020.108064_bib9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00213-018-4836-5","article-title":"Differences in trait impulsivity do not bias the response to pharmacological drug challenge in the rat five-choice serial reaction time task","volume":"235","author":"Barlow","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108064_bib10","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.biopsych.2006.06.030","article-title":"Dimensional analysis of ADHD subtypes in rats","volume":"61","author":"Blondeau","year":"2007","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108064_bib11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuropharm.2005.11.020","article-title":"Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis","volume":"50","author":"Boothman","year":"2006","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108064_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/adb.12168","article-title":"Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making","volume":"20","author":"Broos","year":"2015","journal-title":"Addiction Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108064_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108064_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuropharm.2019.05.016","article-title":"Atomoxetine improves memory and other components of executive function in young-adult rats and aged rhesus monkeys","volume":"155","author":"Callahan","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108064_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S1092852913000564","article-title":"Animal models of obsessive-compulsive spectrum disorders","volume":"19","author":"Camilla d'Angelo","year":"2014","journal-title":"CNS Spectr."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108064_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2714","article-title":"5-HT2C agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: a pilot study","volume":"34","author":"Coccaro","year":"2019","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108064_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2017.12.023","article-title":"The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders","volume":"142","author":"Collins","year":"2018","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108064_bib18","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.npp.1300474","article-title":"Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade","volume":"29","author":"Cremers","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108064_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/wps.20087","article-title":"The RDoC framework: facilitating transition from ICD\/DSM to dimensional approaches that integrate neuroscience and psychopathology","volume":"13","author":"Cuthbert","year":"2014","journal-title":"World Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108064_bib20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1126\/science.1137073","article-title":"Nucleus accumbens D2\/3 receptors predict trait impulsivity and cocaine reinforcement","volume":"315","author":"Dalley","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108064_bib21","first-page":"696","article-title":"Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinic","volume":"9","author":"Day","year":"2008","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2020.108064_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2015.11.009","article-title":"New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders","volume":"157","author":"Di Giovanni","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1098-2779(2000)6:2<125::AID-MRDD6>3.0.CO;2-T","article-title":"Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome","volume":"6","author":"Dimitropoulos","year":"2000","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108064_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biopsych.2010.09.040","article-title":"Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking","volume":"69","author":"Economidou","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108064_bib25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1124\/jpet.108.143420","article-title":"Challenges in the search for drugs to treat central nervous system disorders","volume":"329","author":"Enna","year":"2009","journal-title":"JPET"},{"issue":"3447","key":"10.1016\/j.neuropharm.2020.108064_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/science.133.3447.195","article-title":"Production of polydipsia in normal rats by an intermittent food schedule","volume":"133","author":"Falk","year":"1961","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108064_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0031-9384(71)90209-5","article-title":"The nature and determinants of adjunctive behavior","volume":"6","author":"Falk","year":"1971","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108064_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-011-2408-z","article-title":"Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists","volume":"219","author":"Fernando","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108064_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-clinpsy-032210-104454","article-title":"Animal models of neuropsychiatric disorders","volume":"7","author":"Fernando","year":"2011","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108064_bib30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.euroneuro.2016.04.001","article-title":"Compulsivity-A new trans-diagnostic research domain for the roadmap for mental health research in europe (ROAMER) and research domain criteria (RDoC) initiatives","volume":"26","author":"Fineberg","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108064_bib31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/npp.2009.185","article-title":"Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review","volume":"35","author":"Fineberg","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108064_bib32","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/sj.npp.1301509","article-title":"The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues","volume":"33","author":"Fletcher","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-007-0891-z","article-title":"Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test","volume":"195","author":"Fletcher","year":"2007","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2020.108064_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/11591790-000000000-00000","article-title":"Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments","volume":"71","author":"Fontenelle","year":"2011","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108064_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00148581-200911030-00005","article-title":"Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents","volume":"11","author":"Garnock-Jones","year":"2009","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.neuropharm.2020.108064_bib36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0269881116645269","article-title":"True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence","volume":"30","author":"Goetghebeur","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108064_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2020.108064_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2015.11.010","article-title":"Low attentive and high impulsive rats: a translational animal model of ADHD and disorders of attention and impulse control","volume":"158","author":"Hayward","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108064_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00213-003-1549-0","article-title":"The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism","volume":"170","author":"Higgins","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108064_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107417","article-title":"Lorcaserin: a review of its preclinical and clinical pharmacology and therapeutic potential","author":"Higgins","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.108064_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cpph.27","article-title":"Rodent test of attention and impulsivity: the 5-choice serial reaction time task","volume":"78","author":"Higgins","year":"2017","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"14","key":"10.1016\/j.neuropharm.2020.108064_bib42","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1007\/s00213-016-4329-3","article-title":"Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: implications for understanding the anti-obesity property of 5-HT2C receptor agonists","volume":"233","author":"Higgins","year":"2016","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2020.108064_bib43","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/0269881117735797","article-title":"Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists","volume":"31","author":"Higgins","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"5605","key":"10.1016\/j.neuropharm.2020.108064_bib44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.1077141","article-title":"Medicine. What are the right targets for psychopharmacology?","volume":"299","author":"Hyman","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neuropharm.2020.108064_bib45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108064_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neubiorev.2016.01.013","article-title":"The neurobiological basis of binge-eating disorder","volume":"63","author":"Kessler","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4\u20135","key":"10.1016\/j.neuropharm.2020.108064_bib47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","article-title":"SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"issue":"5758","key":"10.1016\/j.neuropharm.2020.108064_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.1118265","article-title":"The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C","volume":"311","author":"Kishore","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108064_bib49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates?","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2020.108064_bib50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/psyp.12518","article-title":"The NIMH research domain criteria initiative: background, issues, and pragmatics","volume":"53","author":"Kozak","year":"2016","journal-title":"Psychophysiology"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108064_bib51","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1124\/jpet.111.183525","article-title":"Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats","volume":"338","author":"Levin","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2020.108064_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neubiorev.2017.02.004","article-title":"Aligning physiology with psychology: translational neuroscience in neuropsychiatric drug discovery","volume":"76","author":"McArthur","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108064_bib53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4088\/JCP.v68n0306","article-title":"Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial","volume":"68","author":"McElroy","year":"2007","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108064_bib95","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/npp.2008.173","article-title":"Removing obstacles in neuroscience drug discovery: the future path for animal models","volume":"34","author":"Markou","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108064_bib54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0091-3057(01)00713-4","article-title":"Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety","volume":"71","author":"Martin","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib55","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3565(24)37669-4","article-title":"5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential","volume":"286","author":"Martin","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108064_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12489","article-title":"Excessive habit formation in schedule-induced polydipsia: microstructural analysis of licking among rat strains and involvement of the orbitofrontal cortex","volume":"18","author":"Merch\u00e1n","year":"2019","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2020.108064_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pnpbp.2019.03.016","article-title":"Behavioral and biological markers for predicting compulsive-like drinking in schedule-induced polydipsia","volume":"93","author":"Merch\u00e1n","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108064_bib58","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s002130050910","article-title":"5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats","volume":"142","author":"Millan","year":"1999","journal-title":"Psychopharmacology"},{"issue":"4647","key":"10.1016\/j.neuropharm.2020.108064_bib59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.6710151","article-title":"Ingestive behavior evoked by hypothalamic stimulation and schedule-induced polydipsia are related","volume":"224","author":"Mittleman","year":"1984","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108064_bib60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(85)90366-X","article-title":"Individual differences in non-regulatory ingestive behavior and catecholamine systems","volume":"348","author":"Mittleman","year":"1985","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00213-011-2570-3","article-title":"Schedule-induced polydipsia as a model of compulsive behavior: neuropharmacological and neuroendocrine bases","volume":"219","author":"Moreno","year":"2012","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib62","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00213-011-2575-y","article-title":"Poor inhibitory control and neurochemical differences in high compulsive drinker rats selected by schedule-induced polydipsia","volume":"219","author":"Moreno","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108064_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pnpbp.2007.06.017","article-title":"Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test","volume":"32","author":"Navarra","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108064_bib64","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/schbul\/sbw141","article-title":"Behavioral biomarkers of schizophrenia in high drinker rats: a potential endophenotype of compulsive neuropsychiatric disorders","volume":"43","author":"Navarro","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.neuropharm.2020.108064_bib65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00213-014-3699-7","article-title":"Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia","volume":"232","author":"Navarro","year":"2015","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108064_bib66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nbd.2011.08.026","article-title":"Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders","volume":"45","author":"O'Neil","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.108064_bib93","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00213-017-4545-5","article-title":"A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment","volume":"234","author":"Palacios","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108064_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd2094","article-title":"Drug development for CNS disorders: strategies for balancing risk and reducing attrition","volume":"6","author":"Pangalos","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108064_bib68","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/npp.2012.258","article-title":"Impact of serotonin (5-HT)2C receptors on executive control processes","volume":"38","author":"Pennanen","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2020.108064_bib69","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.biopsych.2018.01.014","article-title":"Effective use of animal models for therapeutic development in psychiatric and substance use disorders","volume":"83","author":"Phillips","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108064_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0927s43","article-title":"Schedule-induced polydipsia: a rat model of obsessive-compulsive disorder","author":"Platt","year":"2008","journal-title":"Curr. Protoc. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108064_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2020.108064_bib72","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/nlme.1996.0060","article-title":"Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder","volume":"66","author":"Puumala","year":"1996","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2020.108064_bib73","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0306-4522(97)00392-8","article-title":"Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task","volume":"8","author":"Puumala","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108064_bib74","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","article-title":"The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry","volume":"163","author":"Robbins","year":"2002","journal-title":"Psychopharmacology"},{"issue":"19","key":"10.1016\/j.neuropharm.2020.108064_bib75","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1111\/bph.13826","article-title":"Cross-species studies of cognition relevant to drug discovery: a translational approach","volume":"174","author":"Robbins","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108064_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tics.2011.11.009","article-title":"Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry","volume":"16","author":"Robbins","year":"2012","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2020.108064_bib77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-011-2420-3","article-title":"Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks","volume":"219","author":"Robinson","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108064_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fpsyt.2017.00089","article-title":"Behavioral effects of a novel benzofuranyl-piperazine serotonin-2C receptor agonist suggest a potential therapeutic application in the treatment of obsessive-compulsive disorder","volume":"8","author":"Rodriguez","year":"2017","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108064_bib79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-007-0710-6","article-title":"Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents","volume":"192","author":"Rosenzweig-Lipson","year":"2007","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003495-200464020-00005","article-title":"Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder","volume":"64","author":"Simpson","year":"2004","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib81","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuropharm.2006.07.024","article-title":"CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity","volume":"52","author":"Siuciak","year":"2007","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2020.108064_bib82","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108064_bib83","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrd.2016.85","article-title":"Trends in clinical success rates","volume":"15","author":"Smietana","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.neuropharm.2020.108064_bib84","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00439-017-1826-3","article-title":"The activity of the serotonin receptor 2C is regulated by alternative splicing","volume":"136","author":"Stamm","year":"2017","journal-title":"Hum. Genet."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2020.108064_bib85","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neubiorev.2016.04.019","article-title":"Obsessive-compulsive disorder: insights from animal models","volume":"76","author":"Szechtman","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib86","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","article-title":"Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization","volume":"325","author":"Thomsen","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108064_bib87","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.euroneuro.2014.04.008","article-title":"Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats","volume":"24","author":"Tomlinson","year":"2014","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108064_bib94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2009.08.043","article-title":"Frontal-striatal abnormalities underlying behaviours in the compulsive-impulsive spectrum","volume":"289","author":"van den Heuvel","year":"2010","journal-title":"J Neurol Sci"},{"issue":"10","key":"10.1016\/j.neuropharm.2020.108064_bib88","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/npp.2014.98","article-title":"High trait impulsivity predicts food addiction-like behavior in the rat","volume":"39","author":"Velazquez-Sanchez","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108064_bib89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2008.03.012","article-title":"RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function","volume":"119","author":"Werry","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.108064_bib92","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00213-004-1884-9","article-title":"5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion","volume":"176","author":"Winstanley","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2020.108064_bib90","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02244910","article-title":"Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder","volume":"112","author":"Woods","year":"1993","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108064_bib91","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/15622970009150571","article-title":"Obsessive compulsive disorder: serotonin and beyond","volume":"1","author":"Zohar","year":"2000","journal-title":"World J. Biol. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820301301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820301301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:02:25Z","timestamp":1758438145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820301301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":95,"alternative-id":["S0028390820301301"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108064","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of 5-HT2C receptor modulation and the NA reuptake inhibitor atomoxetine in tests of compulsive and impulsive behaviour","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108064"}}